简体中文 | 繁體中文 | English

Press Releases

2022-01-12 18:51 Perceval: CORCYM Announces the First Patient Implanted in China
2022-01-12 18:49 Lineage Logistics Transitions Operations at its Hvidovre Site in Denmark
2022-01-12 18:47 Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference
2022-01-12 18:32 Lineage Logistics Strengthens European Transport Capability and Expands Benelux Footprint
2022-01-12 16:42 Nam Tai Property Provides Update on Local Affairs and Efforts to Preserve Social Stability
2022-01-12 16:02 Tokyo Stock Exchange Announces Results of Market Segment Selection by Listed Companies
2022-01-12 15:44 Carbon Streaming Welcomes Alice Schroeder to Board of Directors
2022-01-12 15:37 It’s Official! ZBrush is Now Part of the Maxon Family
2022-01-12 14:58 CSC Appoints Remko Dieker as Managing Director in the Netherlands
2022-01-12 10:12 Qraft Technologies Closes US$146 Million Investment from SoftBank Group Entering into a Strategic Partnership to Accelerate AI in the Asset Management Industry
2022-01-12 10:00 PCI-SIG® Releases PCIe® 6.0 Specification Delivering Record Performance to Power Big Data Applications
2022-01-12 09:51 New UltimusPlus-NX Fluid Dispensers Improve Operational Efficiency by Allowing Remote Programming Directly from a PLC
2022-01-12 09:47 DB HiTek Expands RF Front-End Business With RF SOI/HRS Process
2022-01-11 18:17 QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
2022-01-11 17:55 Mary Kay Inc. & Mary Kay Ash FoundationSM Celebrate 2021 Year-End Highlights
2022-01-11 17:42 Loomis Sayles Launches New Private Credit Group Led by Industry Veteran Chris Gudmastad
2022-01-11 16:45 BAI Communications Partners With Mavenir to Deliver Sunderland’s Smart City Project
2022-01-11 09:58 Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology
2022-01-11 09:55 Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers
2022-01-11 09:45 Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma

Business Wire Weibo

Industries

Latest Releases